Activist investor ValueAct Capital Management disclosed on August 15 that it had taken a $1.1 billion stake in Morgan Stanley, signalling a potential rallying cry for bank investors after years of poor returns.

ValueAct's stake of 38 million shares represents about 2% of the shares outstanding in Morgan Stanley. But unlike most activist positions, ValueAct says it is the market, not the company, that has it wrong.